News Home

Can Taysha Gene Therapies Inc (TSHA) Stock Rise to the Top of Healthcare Sector Tuesday?

Tuesday, September 26, 2023 10:38 AM | InvestorsObserver Analysts

Mentioned in this article

Can Taysha Gene Therapies Inc (TSHA) Stock Rise to the Top of Healthcare Sector Tuesday?

Taysha Gene Therapies Inc (TSHA) is near the top in its sector according to InvestorsObserver. TSHA gets an overall rating of 63. That means it scores higher than 63% of stocks. Taysha Gene Therapies Inc gets a 99 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors.

Overall Score - 63
TSHA has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on TSHA!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Taysha Gene Therapies Inc Stock Today?

Taysha Gene Therapies Inc (TSHA) stock is trading at $2.82 as of 10:38 AM on Tuesday, Sep 26, a decline of -$0.14, or -4.73% from the previous closing price of $2.96. The stock has traded between $2.76 and $2.88 so far today. Volume today is low. So far 297,143 shares have traded compared to average volume of 10,177,479 shares. Click Here to get the full Stock Report for Taysha Gene Therapies Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App